Skip to main content

Latest SEC Filings — Page 151

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Chevron CEO Michael Wirth Files to Sell $63.6M in Stock
Form 144CVX · Form 144 · 2026-08-14
Blue Water Acquisition Corp. IV Flags Going Concern Doubt and Material Weakness in Q2 10-Q
ProForm 10-QBWIV · Form 10-Q · 2026-08-14
Bryn Inc. Q2 2026: Going Concern Deepens as Related-Party Debt Swells and Internal Controls Flagged
ProForm 10-QBRRN · Form 10-Q · 2026-08-14
Polomar Health Q2 Revenue Jumps to $1.5M, Turns Profitable, But Going Concern and Material Weaknesses Persist
ProForm 10-QPMHS · Form 10-Q · 2026-08-14
Foresight Q2 2026 Results Highlight Going Concern Doubt and Nasdaq Delisting Risk
ProForm 6-KFRSX · Form 6-K · 2026-08-14
Origin Investment Corp I Raises Going Concern Doubt in Q2 10-Q
ProForm 10-QORIQ · Form 10-Q · 2026-08-14
Accustem Sciences Q2 10-Q: Going Concern Warning, $12.9K Cash, Material Weakness
ProForm 10-QACUT · Form 10-Q · 2026-08-14
SPAC Flags Going Concern as Business Combination Deadline Looms
ProForm 10-QAIIA · Form 10-Q · 2026-08-14
Glucotrack 10-Q: Going Concern, Material Weaknesses, and Nasdaq Delisting Risk
ProForm 10-QGCTK · Form 10-Q · 2026-08-14
VirnetX Flags Going Concern, $20M Shelf, and Insider Sales Plans
ProForm 10-QVHC · Form 10-Q · 2026-08-14
Glass House Brands Q2 Loss Widens, Material Weakness Persists
ProForm 6-KGLAS · Form 6-K · 2026-08-14
SC II Acquisition Corp. Flags Going Concern Doubt in Q2 10-Q
ProForm 10-QSCII · Form 10-Q · 2026-08-14
SoundThinking Q2 10-Q Confirms Revenue Decline, Cash Burn, and Unremediated Material Weaknesses
ProForm 10-QSSTI · Form 10-Q · 2026-08-14
DMAA 10-Q Reveals Material Weakness, Going Concern, and Sponsor Default
ProForm 10-QDMAA · Form 10-Q · 2026-08-14
TDAC's Q2 10-Q Flags Ineffective Disclosure Controls and Going Concern Risk
ProForm 10-QTDAC · Form 10-Q · 2026-08-14
QDM International Q1 Revenue Jumps 133% but Cash Flow Collapses on Prepaid Referral Fees
Form 10-QQDMI · Form 10-Q · 2026-08-14
Edgemode Q2 Loss Widens, Cash Drops to $16,710, Going Concern Doubt Raised
ProForm 10-QEDGM · Form 10-Q · 2026-08-14
ENvue Medical Stockholders Approve Reverse Stock Split to Regain Nasdaq Compliance
Form 8-KFEED · Form 8-K · 2026-08-14
Viking Acquisition Corp. II Flags Going Concern Doubt After $230M IPO
ProForm 10-QVII · Form 10-Q · 2026-08-14
Digimarc's Q2 Loss Widens to $12.1M; Going Concern Warning Reiterated
ProForm 10-QDMRC · Form 10-Q · 2026-08-14
Cantor Equity Partners I Confirms BSTR Merger Termination and Flags Going Concern
ProForm 10-QCEPO · Form 10-Q · 2026-08-14
Quince Therapeutics Flags Going Concern Doubt Amid $75.5M Q2 Loss
ProForm 10-QQNCX · Form 10-Q · 2026-08-14
ENDRA Reports Q2 Profit on Digital Asset Gains, Regains Nasdaq Compliance
ProForm 10-QNDRA · Form 10-Q · 2026-08-14
Shareholders Back Reverse Split to Keep Nasdaq Listing
Form 8-KCTSO · Form 8-K · 2026-08-14
SmartKem 10-Q: Going Concern Warning, Material Weakness, and $125M Ferrox Merger
ProForm 10-QSMTK · Form 10-Q · 2026-08-14
Sphere 3D Posts $13.8M Q2 Loss, Warns Cash May Run Out Within 12 Months
ProForm 10-QANY · Form 10-Q · 2026-08-14
Actuate Therapeutics: Cash Runway to September 2026, Nasdaq Delisting Risk
ProForm 10-QACTU · Form 10-Q · 2026-08-14
Annovis Q2 Loss Widens to $0.40/Share; Cash at $18.7M, Warrant Liability Jumps to $19.9M
Form 8-KANVS · Form 8-K · 2026-08-14
Defense Backlog Hits $1.81B; Q2 EPS $2.21 with More Tariff Refunds Ahead
Form 10-QNPK · Form 10-Q · 2026-08-14
SPAC Flags Going Concern, Material Weakness, and 35% Discount Convertible Notes
ProForm 10-QDMII · Form 10-Q · 2026-08-14